Gordon, L. B., Kleinman, M. E., Massaro, J., D’Agostino, R. B., Shappell, H., Gerhard-Herman, M., . . . Kieran, M. W. (2016). Clinical Trial of Protein Farnesylation Inhibitors Lonafarnib, Pravastatin and Zoledronic Acid in Children with Hutchinson-Gilford Progeria Syndrome. Circulation.
Styl cytowania ChicagoGordon, Leslie B., et al. "Clinical Trial of Protein Farnesylation Inhibitors Lonafarnib, Pravastatin and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome." Circulation 2016.
Styl cytowania MLAGordon, Leslie B., et al. "Clinical Trial of Protein Farnesylation Inhibitors Lonafarnib, Pravastatin and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome." Circulation 2016.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..